Medtronic received information that following implant of this transcatheter bioprosthetic core valve there was moderate aortic regurgitation (ar).A balloon valvuloplasty was performed utilizing a non-medtronic balloon (numed canada inc.Nucleus aortic 20 mm reference number: pvn230 lot: y-3357), however post-valvuloplasty a ventricular septal rupture was documented on transesophageal echocardiogram (tee).The patient was intubated and a second core valve was successfully implanted which rectified the ar from moderate to mild.The ventricular septal rupture had subsequently reduced in size with no further sign of bleeding.Post-procedure (same day) the patient developed a left bundle branch block (lbbb).One day post-implant, complete heart block (chb) was noted when the patient temporary pacing rate was slowed.Also noted was occasional runs of non-sustained ventricular tachycardia, this caused some dizziness and palpitations which was treated with medication.The patient had a pacemaker successfully implanted six days post? implant due to the chb.No additional adverse patient effects were reported.(b)(4) this report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|